Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin
Reference (46)
- et al.
Differential effects of acute dopaminergic D1 and D2 receptor antagonists on proneurotensin mRNA expression in rat striatum
Mol. Brain Res.
(1991) Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons
Neuroscience
(1988)- et al.
Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonists
Eur. J. Pharmacol.
(1989) - et al.
Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats
Brain Res.
(1991) - et al.
Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study
Brain Res.
(1988) - et al.
Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes
Brain Res.
(1990) - et al.
Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat straital neurons
Neuroscience
(1988) - et al.
Neuropeptide Y-immunoreactive neurons receive synaptic inputs from dopaminergic axon terminals in the rat neostriatum
Brain Res.
(1988) - et al.
Protein measurement with the Folin phenol reagent
J. Biol. Chem.
(1951) - et al.
Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density
Brain Res.
(1990)
Dopamine D2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain
Brain Res.
Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens
Eur. J. Pharmacol.
Dopaminergic neurons of the substantia nigra modulate preproenkephalin A gene expression in rat striatal neurons
Brain Res.
Isolated removal of hypothalamic or other brain nuclei of the rat
Brain Res.
Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance
Life Sci.
Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra
Brain Res.
Neuropeptide-Y immunoreactive neurons in the striatum of cat and monkey: morphological characteristics, intrinsic organization and co-localization with somatostatin
Brain Res.
The effect of amphetamine on the in vivo release of dopamine, somatostatin and neuropeptide Y from rat caudate nucleus
Brain Res.
Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [met5]- and [leu5]-enkephalin and neurotensin content in rat brain
Biochem. Pharmacol.
Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxytryptamine lesions
Brain Res.
Ultrastructural correlates of functional relationships between nigral dopaminergic or cortical afferent fibers and neuropeptide Y-containing neurons in the rat striatum
Neurosci. Lett.
Responses of substantia nigra pars reticulata neurons to GABA and SKF 38393 in 6-hydroxydopamine-lesioned rats are differentially affected by continuous and intermittent levodopa administration
Brain Res.
Regional distribution and regulation of preprosomatostatin messenger RNA in the striatum, as revealed by in sity hybridization histochemistry
Mol. Brain. Res.
Cited by (120)
Dissociation of impulsivity and aggression in mice deficient for the ADHD risk gene Adgrl3: Evidence for dopamine transporter dysregulation
2019, NeuropharmacologyCitation Excerpt :Striatal dopamine transporter levels have been implicated in the response of individuals with ADHD to MPH; however, unlike in the PFC, dopaminergic gene expression in the striatum does not seem to be directly impacted by the depletion of ADGRL3 (Krause et al., 2005). Differential gene expression in both the PFC and striatum may be linked as dopaminergic modulation is known to regulate striatal neuropeptide levels (Engber et al., 1992). Both Hypocretin and Pmch code for neuropeptides and were disrupted in the striatum of Adgrl3−/− mice.
Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases
2016, Neurobiology of DiseaseEnkephalin and dynorphin neuropeptides are differently correlated with locomotor hypersensitivity and levodopa-induced dyskinesia in parkinsonian rats
2016, Experimental NeurologyCitation Excerpt :Moreover, hypersensitivity of the DA-denervated brain area alters the locomotor responses to DA treatment: on/off motor fluctuations arise in human PD patients, and circling behavior is seen in parkinsonian rats. The pharmacological replacement of striatal DA with l-dihydroxyphenylalanine (l-DOPA), which is the most effective medical treatment for PD, substantially alters prodynorphin (PDYN) and preproenkephalin (PPENK) mRNA expression in the rat striatum, with differential localization in the lateral and medial striatal regions (Aubert et al., 2007; Engber et al., 1992; Gerfen et al., 1990, 1991; Westin et al., 2001). These two regions are involved in the control of axial and limb movements and of locomotor activity, respectively (Pisa, 1988; Andersson et al., 1999).
Interaction between dopamine and neuropeptide Y in the telencephalon of the Indian major carp, Cirrhinus cirrhosus
2015, General and Comparative EndocrinologyMean-field modeling of the basal ganglia-thalamocortical system. I. Firing rates in healthy and parkinsonian states
2009, Journal of Theoretical Biology